医学
四分位数
内科学
逻辑回归
血管病学
心脏病学
接收机工作特性
全国健康与营养检查调查
优势比
弗雷明翰风险评分
切断
全国死亡指数
流行病学
索引(排版)
风险评估
拐点
冠状动脉疾病
冠心病
风险因素
混淆
子群分析
可能性
急性冠脉综合征
作者
Pan Jia,Mamajan Annamyradova,Genhao Fan,Qizhen Zhang,Yankun Song,Qiaozhi Li,Minghao Liu,Zuoying Xing,Yongxia Wang
标识
DOI:10.1186/s12872-025-05166-w
摘要
Although the fibrosis-4 index (FIB‐4) was initially established as a liver fibrosis marker, recent studies have demonstrated its significant association with elevated risk of coronary artery disease(CHD). This study was conducted using data from five National Health and Nutrition Examination Surveys (NHANES) cycles between 2009 and 2018. Multivariable logistic regression analysis revealed a significant, positive relationship between FIB-4 and CHD.In sensitivity analyses, the highest FIB-4 quartile (Q4) showed a 4.22-fold increased CHD risk versus Q1 (OR = 4.22, 95% CI:1.93–9.24, P = 0.0005), with significant dose-response trends across quartiles (P < 0.05). Receiver operating characteristic (ROC) analysis revealed FIB-4 had good discriminative power for CHD (AUC = 0.80, 95%CI:0.78–0.81), with 75.9% sensitivity and 30.2% specificity at the optimal cutoff of 1.31. Restricted cubic splines (RCS) analysis revealed a nonlinear dose-response relationship between FIB-4 and CHD risk (P < 0.0001), with accelerated risk elevation beyond the inflection point (FIB-4 = 2.73). Subgroup analyses confirmed FIB-4’s robust association with CHD risk (overall OR = 1.66, 95%CI:1.57–1.76), with stronger effects in males (vs. females, Pinteraction = 0.042), non-diabetics (vs. diabetics, Pinteraction < 0.001), and racial minorities (highest OR = 2.36 in ‘Other Race’).These findings underscore the potential of FIB-4 as a novel biomarker for CHD risk assessment in clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI